Detalhe da pesquisa
1.
DNA methylation profiling identifies EYA4 gene as a prognostic molecular marker in hepatocellular carcinoma.
Ann Surg Oncol
; 21(12): 3891-9, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24306662
2.
Simvastatin enhances the chemotherapeutic efficacy of S-1 against bile duct cancer: E2F-1/TS downregulation might be the mechanism.
Anticancer Drugs
; 24(10): 1020-9, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23941814
3.
Analysis of the genome-wide DNA methylation profile of side population cells in hepatocellular carcinoma.
Dig Dis Sci
; 58(7): 1934-47, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23625283
4.
Angiotensin receptor blockers retard the progression and fibrosis via inhibiting the viability of AGTR1+ CAFs in intrahepatic cholangiocarcinoma.
Clin Transl Med
; 13(3): e1213, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36855786
5.
Outcomes of non-anatomic liver resection for hepatocellular carcinoma in the patients with liver cirrhosis and analysis of prognostic factors.
Langenbecks Arch Surg
; 396(2): 193-9, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20852883
6.
EYA4 inhibits hepatocellular carcinoma growth and invasion by suppressing NF-κB-dependent RAP1 transactivation.
Cancer Commun (Lond)
; 38(1): 9, 2018 04 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29764501
7.
EYA4 functions as tumor suppressor gene and prognostic marker in pancreatic ductal adenocarcinoma through ß-catenin/ID2 pathway.
Cancer Lett
; 380(2): 403-412, 2016 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27378242
8.
EYA4 gene functions as a prognostic marker and inhibits the growth of intrahepatic cholangiocarcinoma.
Chin J Cancer
; 35(1): 70, 2016 07 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-27469137
9.
Sorafenib enhances the chemotherapeutic efficacy of S-1 against hepatocellular carcinoma through downregulation of transcription factor E2F-1.
Cancer Chemother Pharmacol
; 71(5): 1255-64, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23435877